Related Experiment Videos
Cholesterol-binding cytolytic protein toxins
1Institut Pasteur de Lille, France.
International Journal of Medical Microbiology : IJMM
|December 9, 2000
Summary
Cholesterol-binding cytolysins (CBCs) are bacterial toxins that lyse eukaryotic cells by binding to membrane cholesterol. Structure-activity studies reveal key residues and domains critical for their lytic function and cholesterol interaction.
Area of Science:
- Microbiology
- Biochemistry
- Structural Biology
Background:
- Cholesterol-binding cytolysins (CBCs) are a diverse family of bacterial toxins.
- These toxins are produced by various Gram-positive bacteria and are lethal and lytic to eukaryotic cells.
- Their activity is dependent on membrane cholesterol and sulfhydryl groups.
Purpose of the Study:
- To investigate the structure-activity relationships of cholesterol-binding cytolysins.
- To identify key molecular determinants responsible for toxin binding to cholesterol and lytic activity.
- To understand the mechanism of pore formation in eukaryotic cell membranes.
Main Methods:
- Sequence analysis of cloned toxin genes.
- Site-directed mutagenesis of conserved residues, particularly cysteine and tryptophan.
- Elucidation of the 3-D structure of perfringolysin O.
- Biochemical assays to assess lytic activity and cholesterol binding.
Main Results:
- CBCs exhibit sequence homology, especially in the C-terminal region, with a conserved consensus sequence.
- A specific tryptophan residue in the conserved undecapeptide was found to be critical for lytic activity.
- The 3-D structure of perfringolysin O revealed four domains, with domain 4 mediating membrane interaction and a Trp-rich region adapting to cholesterol.
- Oligomerization involves multiple sites, leading to pore formation.
Conclusions:
- Cholesterol is the primary binding site for CBCs on eukaryotic cell membranes.
- Specific residues, particularly tryptophan, and structural domains are crucial for the lytic function of CBCs.
- The mechanism involves monomer binding, oligomerization, and pore formation, with conformational changes driven by cholesterol interaction.